Search results for " market"
Article
Welcome to the new Process Development Forum
August 15, 2013
Welcome to the new Bioprocess Development Forum (PDF) website.
We launched www.ProcessDevelopmentForum.com two years ago as a new channel for information relevant to research…
Article
QbD and PAT in Upstream and Downstream Processing
…l pharma companies in order to ensure a fast-track initiative from R&D to license to operate and market). The risk assessment includes a review and assessment of the products CQAs when manufactured o…
Article
Addressing the Challenges in Downstream Processing Today and Tomorrow
Newer classes of biotherapies will require innovations in processing technology.
By Glen R. Bolton, Bernard N. Violand, Richard S. Wright, Shujun Sun, Khurram M. Sunasara, Kathleen Watson, Johna…
Resource
FDA’s Adverse Event Reporting System (AERS)
The FDA uses AERS to monitor for new adverse events and medication errors that might occur with these marketed products.
About
About Us
Process Development Forum is an online resource for biopharmaceutical researchers, scientists, and process engineers what are interested in information on innovations and te…